ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Isospec Analytics has raised $1.9 million in preseed funding to develop technology for rapidly identifying unknown molecules. Isospec was founded in 2022 to commercialize a technique originating from the Laboratory of Molecular Physical Chemistry at the Swiss Federal Institute of Technology, Lausanne (EPFL). The firm says its technology is already being used to analyze sugars and metabolites but that its real potential is in the discovery of new biomarkers for drugs and diagnostics.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X